Reuters logo
BRIEF-Cytodyn receives orphan drug designation for PRO 140
2017年10月5日 / 上午10点21分 / 12 天前

BRIEF-Cytodyn receives orphan drug designation for PRO 140

Oct 5 (Reuters) - Cytodyn Inc:

* Cytodyn receives orphan drug designation for PRO 140 for prevention of graft versus host disease Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below